Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry)
To access this article, please choose from the options below
This study was supported by Cordis Cardiology Japan, a Johnson and Johnson Company, Tokyo, Japan.
PII: S0002-9149(10)00780-0
doi:10.1016/j.amjcard.2010.03.031
© 2010 Elsevier Inc. All rights reserved.
